Form 8-K - Current report:
SEC Accession No. 0001193125-26-224080
Filing Date
2026-05-14
Accepted
2026-05-14 16:17:07
Documents
11
Period of Report
2026-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnxt-20260514.htm   iXBRL 8-K 60889
2 EX-99.1 rnxt-ex99_1.htm EX-99.1 315512
3 GRAPHIC img91788333_0.jpg GRAPHIC 9875
  Complete submission text file 0001193125-26-224080.txt   1834209

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnxt-20260514.xsd EX-101.SCH 984746
15 EXTRACTED XBRL INSTANCE DOCUMENT rnxt-20260514_htm.xml XML 4887
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 26979213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)